QQ客服 官方微博 反馈留言

	Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China
	Wang, Kaidi; Xu, Li; Yuan, Zhilan; Yao, Ke; Zhao, Junmei; Xu, Liang; Fang, Aiwu; Zhang, Mingzhi; Wu, Lingling; Ji, Jian
刊名	BMC OPHTHALMOLOGY
	2014
卷号	14
关键词	Bimatoprost Glaucoma Ocular hypertension Intraocular pressure Conjunctival hyperemia
ISSN号	1471-2415
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4887608
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Wang, Kaidi,Xu, Li,Yuan, Zhilan,et al. Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China[J]. BMC OPHTHALMOLOGY,2014,14.
APA	Wang, Kaidi.,Xu, Li.,Yuan, Zhilan.,Yao, Ke.,Zhao, Junmei.,...&Sun, Xinghuai.(2014).Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China.BMC OPHTHALMOLOGY,14.
MLA	Wang, Kaidi,et al."Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China".BMC OPHTHALMOLOGY 14(2014).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。